Results 41 to 50 of about 174,408 (264)

COVID-19: Vaccines and therapeutics

Bioorganic & Medicinal Chemistry Letters, 2022
Coronavirus disease 2019 (COVID-19) is a communicable disease triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as leading cause of death from a single infectious agent globally. Despite of rigorous protective measures, availability of multiple vaccines and with few approved therapeutics, the virus effect on the ...
Ponnampalli, Swapna, Venkata Suryanarayana Birudukota, Naga, Kamal, Ahmed   +2 more
openaire   +2 more sources

Examining the Utility of Social Media in COVID-19 Vaccination: Unsupervised Learning of 672,133 Twitter Posts

JMIR Public Health and Surveillance, 2021
BackgroundAlthough COVID-19 vaccines have recently become available, efforts in global mass vaccination can be hampered by the widespread issue of vaccine hesitancy.
Tau Ming Liew, Cia Sin Lee
doaj   +1 more source

COVID-19 Vaccination and Glomerulonephritis [PDF]

Kidney International Reports, 2021
mRNA COVID-19 vaccine is more effective than traditional vaccines owing to superior immune activation. Nevertheless, the impact of mRNA COVID-19 vaccine on triggering de novo/relapsing glomerulonephritis (GN) is limited. We report a case series of patients who developed new or relapsing GN postvaccination.We evaluated baseline characteristics, vaccine ...
Nattawat Klomjit, Mariam Priya Alexander, Fernando C. Fervenza, Ziad Zoghby, Arvind Garg, Marie C. Hogan, Samih H. Nasr, Marwan Abu Minshar, Ladan Zand   +8 more
openaire   +2 more sources

COVID-19 vaccination and long COVID-19 [PDF]

Reviews in Clinical Medicine
According to the literature, COVID-19 vaccines reduce long COVID-19 symptoms such as cognitive dysfunction, kidney diseases, myalgia, and sleeping disorders (5-7).
Ava Ghezel, Chista Arfaee
doaj   +1 more source

Comparison of the post-marketing safety profile between influenza and COVID-19 vaccines: An analysis of the vaccine adverse event reporting system

Saudi Pharmaceutical Journal, 2022
The global coronavirus disease (COVID-19) epidemic can be partially managed by vaccines; however, the public must be informed about the safety of COVID-19 vaccines to avoid hesitancy.
Abdullah K. Al-Ahmari, Amnah AlAsmari, Anoud AlKorbi, Nehad J Ahmed, Ziyad S. Almalki, Ahmed M. Alshehri, Ahmed A. Albassam, Ghada M. Alem   +7 more
doaj   +1 more source

Recombinant vaccines for COVID-19 [PDF]

Human Vaccines & Immunotherapeutics, 2020
SARS-CoV-2, the causative agent of COVID-19, has imposed a major public health threat, which needs effective therapeutics and vaccination strategies. Several potential candidate vaccines being rapidly developed are in clinical evaluation. Considering the crucial role of SARS-CoV-2 spike (S) glycoprotein in virus attachment, entry, and induction of ...
Yadav, Tushar, Srivastava, Nishant, Mishra, Gourav, Dhama, Kuldeep, Kumar, Swatantra, Puri, Bipin, Saxena, Shailendra K   +6 more
openaire   +3 more sources

HIV infection and the implication for COVID‐19 vaccination

Public Health Challenges, 2022
Human immunodeficiency virus (HIV) is associated with altered cellular and humoral immune response, especially in patients with an untreated or chronic infection.
Tope Oyelade, Reynie Purnama Raya, Kamaluddin Latief   +2 more
doaj   +1 more source

The hindrances to perform the COVID-19 vaccination in Brazil

Human Vaccines & Immunotherapeutics, 2021
Introduction Brazil is one of the epicenters of COVID-19 pandemic and faces several hindrances to make his COVID-19 vaccination plan efficient. Methods The Brazilian COVID-19 vaccination plan was evaluated and the hindrances to make the COVID-19 ...
Matheus Negri Boschiero, Camila Vantini Capasso Palamim, Fernando Augusto Lima Marson   +2 more
doaj   +1 more source

Timelines of COVID-19 Vaccines

Current Medicine Research and Practice, 2020
World Health Organisation discussed the “Top Threats to Human Health in 2019,” and developed a strategic plan to meet the challenges. Among the communicable diseases. Emerging and Re-emerging viral pathogens causing Global Pandemic with devastating results were emphasised.
openaire   +3 more sources

Nanomedicine and the COVID-19 vaccines [PDF]

Nature Nanotechnology, 2020
Two nanoparticle-based vaccines close to obtaining approval by the US Food and Drug Administration could represent a giant step in the fight against the COVID-19 pandemic.
openaire   +2 more sources